View in EDS HTML Full Text PDF Full Text

Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients With Cystic Fibrosis.

Saved in:
Bibliographic Details
Title: Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients With Cystic Fibrosis.
Authors: Rolsma SL; Vanderbilt Vaccine Research Program, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.; Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee., Sokolow A; Division of Pediatric Pulmonary Medicine, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee., Patel PC; Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, Tennessee., Sokolow K; Vanderbilt Vaccine Research Program, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee., Jimenez-Truque N; Vanderbilt Vaccine Research Program, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.; Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee., Fissell WH; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Ryan V; Vanderbilt Vaccine Research Program, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee., Kirkpatrick CM; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia., Nation RL; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia., Gu K; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Teresi M; Department of Internal Medicine, University of Iowa, Iowa City, Iowa., Fishbane N; The Emmes Company LLC, Rockville, Maryland., Kontos M; The Emmes Company LLC, Rockville, Maryland., An G; Department of Internal Medicine, University of Iowa, Iowa City, Iowa., Winokur P; Department of Internal Medicine, University of Iowa, Iowa City, Iowa., Landersdorfer CB; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia., Creech CB; Vanderbilt Vaccine Research Program, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.; Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
Source: The Journal of infectious diseases [J Infect Dis] 2025 Feb 20; Vol. 231 (2), pp. e364-e374.
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39344185
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients With Cystic Fibrosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rolsma+SL%22">Rolsma SL</searchLink>; Vanderbilt Vaccine Research Program, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.; Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Sokolow+A%22">Sokolow A</searchLink>; Division of Pediatric Pulmonary Medicine, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Patel+PC%22">Patel PC</searchLink>; Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Sokolow+K%22">Sokolow K</searchLink>; Vanderbilt Vaccine Research Program, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Jimenez-Truque+N%22">Jimenez-Truque N</searchLink>; Vanderbilt Vaccine Research Program, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.; Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Fissell+WH%22">Fissell WH</searchLink>; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Ryan+V%22">Ryan V</searchLink>; Vanderbilt Vaccine Research Program, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Kirkpatrick+CM%22">Kirkpatrick CM</searchLink>; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Nation+RL%22">Nation RL</searchLink>; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Gu+K%22">Gu K</searchLink>; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Teresi+M%22">Teresi M</searchLink>; Department of Internal Medicine, University of Iowa, Iowa City, Iowa.<br /><searchLink fieldCode="AU" term="%22Fishbane+N%22">Fishbane N</searchLink>; The Emmes Company LLC, Rockville, Maryland.<br /><searchLink fieldCode="AU" term="%22Kontos+M%22">Kontos M</searchLink>; The Emmes Company LLC, Rockville, Maryland.<br /><searchLink fieldCode="AU" term="%22An+G%22">An G</searchLink>; Department of Internal Medicine, University of Iowa, Iowa City, Iowa.<br /><searchLink fieldCode="AU" term="%22Winokur+P%22">Winokur P</searchLink>; Department of Internal Medicine, University of Iowa, Iowa City, Iowa.<br /><searchLink fieldCode="AU" term="%22Landersdorfer+CB%22">Landersdorfer CB</searchLink>; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Creech+CB%22">Creech CB</searchLink>; Vanderbilt Vaccine Research Program, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.; Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220413675%22">The Journal of infectious diseases</searchLink> [J Infect Dis] 2025 Feb 20; Vol. 231 (2), pp. e364-e374.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413675 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6613 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221899%22">00221899 </searchLink><i>NLM ISO Abbreviation: </i>J Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39344185
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/infdis/jiae451
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e364
    Titles:
      – TitleFull: Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients With Cystic Fibrosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rolsma SL
      – PersonEntity:
          Name:
            NameFull: Sokolow A
      – PersonEntity:
          Name:
            NameFull: Patel PC
      – PersonEntity:
          Name:
            NameFull: Sokolow K
      – PersonEntity:
          Name:
            NameFull: Jimenez-Truque N
      – PersonEntity:
          Name:
            NameFull: Fissell WH
      – PersonEntity:
          Name:
            NameFull: Ryan V
      – PersonEntity:
          Name:
            NameFull: Kirkpatrick CM
      – PersonEntity:
          Name:
            NameFull: Nation RL
      – PersonEntity:
          Name:
            NameFull: Gu K
      – PersonEntity:
          Name:
            NameFull: Teresi M
      – PersonEntity:
          Name:
            NameFull: Fishbane N
      – PersonEntity:
          Name:
            NameFull: Kontos M
      – PersonEntity:
          Name:
            NameFull: An G
      – PersonEntity:
          Name:
            NameFull: Winokur P
      – PersonEntity:
          Name:
            NameFull: Landersdorfer CB
      – PersonEntity:
          Name:
            NameFull: Creech CB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 02
              Text: 2025 Feb 20
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1537-6613
          Numbering:
            – Type: volume
              Value: 231
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: The Journal of infectious diseases
              Type: main
ResultId 1